For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Triostat | Active Medication - Synthetic Thyroid Hormone Triostat: Bolus of Triiodothyronine followed by infusion for 48 hours | 6 | None | 11 | 110 | 17 | 110 | View |
| Placebo | Placebo Control Placebo: Bolus of Placebo followed by infusion for 48 hours | 3 | None | 11 | 110 | 20 | 110 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Sentinel | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA (10.0) | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Cardiac Arrhythmia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDRA (10.0) | View |